RE: Some Clarifications7 Jun 2023 07:40
To be fair Guy It does seam unlikely that Bill Newman would be involved in developing a second beside test for hearing antibiotic induced hearing lose after spending 5 years working with GDR on one.
It might be they are not allowed to say they are involved yet but it is highly unlikely they are not part on Devotes project one and two in my book.
I am always a little warry of people claiming to have got information direct from the company.. They may or may not have, but I know, even knowing people there how difficult it is to get the time of day from them never mind anything useful or Market sensitive.
So as I say He may have found a loose lipped employee or may not have.
I do find it interesting that people have assumed that Devote with be giving GDR lumps of money (again they might) I would consider it far more likely that they fund or part fund roll outs in Hospitals in the North West and help raise the profile of the tests rather than depositing large sums of cash with GDR, but we see I may be wrong there to. TBH I would be happy with either,.
iIam convinced that Devote and GDR are or will be working closely together on at least Devotes projects 1 and 2.
Project 1: development and commercialisation of a
bedside point of care genetic test to improve outcome from stroke. Project 2 - development of an ultrarapid point genetic assay to prevent antibiotic induced hearing loss. Project 3 - project to develop
comprehensive pharmacogenetics assay to improve efficacy and safety of prescription of man